FDA announces activities against COVID-19 in a new “At-a-Glance Summary”

2024-02-07T16:10:56+00:00April 17th, 2020|Categories: Clinical Trial, Compliance, Covid-19, Regulatory, USA|Tags: , , |

The FDA has posted a new “At-a-Glance Summary” that captures the agency’s major activities in the fight against COVID-19. The FDA has made a wide range of information regarding their activities available to the public on their COVID19 website. [...]

US FDA Reactions to mitigate pandemic impact on industry and the public

2024-02-29T16:35:19+00:00March 31st, 2020|Categories: Clinical Trial, Covid-19, USA|Tags: , , , |

While global markets are being impacted by COVID-19 pandemic, FDA issues various statements regarding measures to tackle the negative impact on industry and people. Following, we provide a summary of FDA recently introduced regulatory policies. March 31 The FDA [...]

FDA GUIDELINE FOR CLINICAL TRIALS OF MEDICAL PRODUCTS DURING PANDEMIC

2024-02-07T16:14:45+00:00March 18th, 2020|Categories: Covid-19, USA|Tags: , , , |

As the COVID-19 emergency impacts all healthcare sectors, the FDA issues guidelines to help industry and researchers. Safeguard of patients’ safety is the key concern, but also avoiding the compromised integrity of important studies due to missing data and [...]

Go to Top